ChassĂ© M, McIntyre L, English SW, Tinmouth A, Knoll G, Wolfe D, Wilson K, Shehata N, Forster A, van Walraven C, Fergusson DA. Effect of Blood Donor Characteristics on Transfusion Outcomes: A Systematic Review and Meta-Analysis. Transfus Med Rev 2016;30(2):69â€“80.
Knoll GA, Fergusson D, ChassĂ© M, Hebert P, Wells G, Tibbles LA, Treleaven D, Holland D, White C, Muirhead N, Cantarovich M, Paquet M, Kiberd B, Gourishankar S, Shapiro J, Prasad R, Cole E, Pilmore H, Cronin V, Hogan D, Ramsay T, Gill J. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol 2016;4(4):318â€“26.
Lacroix J, HĂ©bert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, Clayton L, McIntyre L, Callum J, Turgeon AF, Blajchman MA, Walsh TS, Stanworth SJ, Campbell H, Capellier G, Tiberghien P, Bardiaux L, van de Watering L, van der Meer NJ, Sabri E, Vo D; ABLE Investigators and the Canadian Critical Care Trials Group. Age of Transfused Blood in Critically Ill Adults. N Engl J Med 2015;372(15):1410â€“8.
Molnar A, Fergusson D, Tsampalieros A, Knoll G, Bennett A, Fergusson N, Ramsay T. Generic immunosuppression in solid organ transplantation: a systematic review and meta-analysis. BMJ. 2015;350:h3163.
Elliott JH, Grimshaw J, Altman R, Bero L, Goodman SN, Henry D, Macleod M, Tovey D, Tugwell P, White H, Sim I. Informatics: Make sense of health data. Nature 2015;527(7576):31â€“2.
Neta G, Glasgow RE, Carpenter CR, Grimshaw JM, Rabin BA, Fernandez ME, Brownson RC. A framework for enhancing the value of research for dissemination and implementation. Am J Public Health 2015; 105(1):49â€“57.
Presseau J, Ivers NM, Newham JJ, Knittle K, Danko KJ, Grimshaw JM. Using a behaviour change techniques taxonomy to identify active ingredients within trials of implementation interventions for diabetes care. Implement Sci. 2015;10:55.
2015â€“2018. CIHR ($394,050). Tranexamic acid during cystectomy trial (TACT). Co-PI: Dean Fergusson
2015â€“2018. OSSU ($1,456,990). A Pragmatic Strategy Empowering Paramedics to Assess Low-Risk Trauma Patients with the Canadian C-Spine Rule and Selectively Transport them Without Immobilization). Co-PI: Dean Fergusson
2016â€“2021. CIHR ($1,490,000). Transfusion in Traumatic Brain Injury Trial (TSiTBI Trial) Co-PI: Dean Fergusson
2015â€“2022. CIHR ($2,128,007). Promoting Implementation of Evidence-Based Care. Project Lead: Jeremy Grimshaw
2009â€“2015. CIHR ($1,400,000). Canadian Research Chair of Health Knowledge Transfer and Uptake (Tier 1 chair) renewal. PI: Jeremy Grimshaw
2010â€“2015. CIHR ($3,035,000). Knowledge Synthesis and Translation by Cochrane Canada. PI: Jeremy Grimshaw
The Division of Critical Care Medicine at the Department of Medicine, University of Ottawa is unique in that it is in fact an Interdepartmental Division, and thus has members from the Departments of Medicine, Surgery and Anesthesiology.Â This multi-specialty makeup enables the Division to provide the broadest scope of expertise in the management of critically ill patients in the Intensive Care Units (ICU) at the Civic and General Campuses of The Ottawa Hospital.
Ottawa has achieved much success in the education, clinical epidemiology and administrative fields, all of which has been designed to improve patient care for critically ill patients.Â To keep expanding on these successes, Critical Care is recruiting new members to explore areas of academic interest, and to enhance the areas of academic strength.Â True to its multi-specialty background, Critical Care is also collaborating with many Departments within The Ottawa Hospital, and other hospitals within the Champlain Local Health Integration Network (LHIN), and the Royal College of Physicians and Surgeons of Canada (RCPSC) to ensure that these successes translate to improved patient care for all critically ill patients.
The Division of Critical Care boasts a well established and nationally recognized tradition of conducting research for the critically ill patient. We have a collaborative team that is well-trained, motivated, and dynamic and we have the necessary research infrastructure to support this terrific team. Many of our research programs are recognized nationally and internationally and include the study of resuscitation and transfusion, monitoring the variability of complex physiological systems, drug safety and compatibility in the critically ill and vascular health in the peril-operative patient population. Research conducted by the Division of Critical Care in Ottawa is done through teamwork, mentorship and through collaborative links with the highly-respected and productive Canadian Critical Care Trials Group.
We continue to maintain a successful translational research program, despite a very small faculty size. This past year 177 patients were enrolled in randomized clinical trials, with an additional 74 patients enrolled in observational trials.
Â From a faculty perspective, nine Principal Investigator research grants and eleven co-Investigator grants were awarded this past year, totally over 1.5 million dollars.
Through the University of Ottawa, the Division of Critical Care offers a comprehensive Residency program in Adult Critical Care Medicine. It has received full accreditation from the Royal College of Physicians and Surgeons of Canada (RCPSC), with strengths in clinical training and excellence in medical education and research. The Division of Critical Care also supports Undergraduate and Postgraduate Electives.
The Division of Critical Care Medicine cares for critically ill patients in the Intensive Care Units (ICU) at both the Civic and General Campuses.Â Both ICUs work as medical-surgical units, with staff physicians providing 24-hour care for their patients.Â Â The multi-specialty makeup of the Department enables clinical expertise in Medical, Surgical and Anesthesiology care to be provided to the ICU patients by the ICU staff physicians.
THE OTTAWA HOSPITAL, CIVIC CAMPUS, 1053 Carling Avenue, OttawaÂ ONÂ K1Y 4E9
THE OTTAWA HOSPITAL, GENERAL CAMPUS, 501 Smyth Road, Ottawa ONÂ K1H 8L6